Research ArticleCLINICAL INVESTIGATIONS
A New Acycloguanosine-Specific Supermutant of Herpes Simplex Virus Type 1 Thymidine Kinase Suitable for PET Imaging and Suicide Gene Therapy for Potential Use in Patients Treated with Pyrimidine-Based Cytotoxic Drugs
Yury Likar, Konstantin Dobrenkov, Malgorzata Olszewska, Elena Vider, Larissa Shenker, Shangde Cai, Nagavarakishore Pillarsetty, Hedvig Hricak and Vladimir Ponomarev
Journal of Nuclear Medicine May 2008, 49 (5) 713-720; DOI: https://doi.org/10.2967/jnumed.107.046425
Yury Likar
Konstantin Dobrenkov
Malgorzata Olszewska
Elena Vider
Larissa Shenker
Shangde Cai
Nagavarakishore Pillarsetty
Hedvig Hricak
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
A New Acycloguanosine-Specific Supermutant of Herpes Simplex Virus Type 1 Thymidine Kinase Suitable for PET Imaging and Suicide Gene Therapy for Potential Use in Patients Treated with Pyrimidine-Based Cytotoxic Drugs
Yury Likar, Konstantin Dobrenkov, Malgorzata Olszewska, Elena Vider, Larissa Shenker, Shangde Cai, Nagavarakishore Pillarsetty, Hedvig Hricak, Vladimir Ponomarev
Journal of Nuclear Medicine May 2008, 49 (5) 713-720; DOI: 10.2967/jnumed.107.046425
A New Acycloguanosine-Specific Supermutant of Herpes Simplex Virus Type 1 Thymidine Kinase Suitable for PET Imaging and Suicide Gene Therapy for Potential Use in Patients Treated with Pyrimidine-Based Cytotoxic Drugs
Yury Likar, Konstantin Dobrenkov, Malgorzata Olszewska, Elena Vider, Larissa Shenker, Shangde Cai, Nagavarakishore Pillarsetty, Hedvig Hricak, Vladimir Ponomarev
Journal of Nuclear Medicine May 2008, 49 (5) 713-720; DOI: 10.2967/jnumed.107.046425